Abstract
Retinopathy of prematurity (ROP) is a vasoproliferative disorder occurring in premature infants’ retinas. With the advances in neonatal care in recent years, ophthalmologists are increasingly encountering premature babies, who have higher risks of developing ROP. The occurrence and severity of ROP depend on several factors, which have been reported by various clinical trials. This chapter demonstrates the evolution of several aspects of major clinical trials in ROP, including its treatment, the role of oxygen in ROP development, and the roles of light and nutrients in ROP.
| Original language | English |
|---|---|
| Title of host publication | A Quick Guide to Pediatric Retina |
| Publisher | Springer Nature |
| Pages | 21-27 |
| Number of pages | 7 |
| ISBN (Electronic) | 9789811565526 |
| ISBN (Print) | 9789811565519 |
| DOIs | |
| Publication status | Published - 1 Jan 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Clinical trials
- Light
- Retinopathy of prematurity
- Treatment Oxygen
Fingerprint
Dive into the research topics of 'Evolution of Major Clinical Trials in ROP'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver